Fifty 410 review
The regulatory record comes first here because it is about this website: in February 2026 the FDA wrote to Aspen Aesthetics, trading as Fifty 410, over false or misleading claims concerning the compounded semaglutide and tirzepatide sold on fifty410.com. On price, the tiles need reading twice — "$133/month" appears beside "$399 total (3 months)", so it is a prepaid quarter divided by three rather than a rate you can start and stop. The higher tier is $549 for three months. Semaglutide is named in the product headings throughout but carries no price of its own, and the site does not say which states it covers.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Fifty 410 at a glance
- Semaglutide
- No separate price published
- Tirzepatide
- $133/mo, but only as a prepaid 3-month package
- Coverage
- Not stated on the site
- Brand-name
- Compounded only
How we scored Fifty 410
Each score comes out of Fifty 410's published pricing, disclosures and oversight, and the six combine into the 32/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
The headline rate obscures a plan requirement or a hidden step-up.
Cost is unpredictable, premium, or hides behind a plan commitment.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- fifty410.com
Checked against Fifty 410's own site and the FDA warning-letter record in August 2026. The FDA wrote to its operator in February 2026 about false or misleading claims for the compounded semaglutide and tirzepatide sold on this website. Its "$133/month" is a prepaid three-month package of $399 rather than a monthly rate, the higher tier is $549 for three months, and semaglutide has no published price of its own.
What to expect when you sign up
We walked Fifty 410's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action leaves fifty410.com for intakeq.com, a separate host
- 2The intake responded HTTP 200 when checked on 2026-08-21
- 3Walked to the intake entry only. No personal information was submitted, so nothing past the entry screen is asserted here
What we noticed
- The intake runs on IntakeQ rather than on the provider's own software
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
- Intake is hosted on intakeq.com, so the company you fill the form in with is not the domain you started on
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded tirzepatide | $133 | Starter, 3-month prepaid"$133/month" sits beside "$399 total (3 months)" — 399 divided by 3, paid up front. |
| Compounded tirzepatide | $183 | High dose, 3-month prepaid"$183/month" beside "$549 total (3 months)". |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Fifty 410's public disclosures at last review and change often; confirm the current number on Fifty 410's own site.
What we like
- Publishes package totals alongside the per-month equivalents rather than only the smaller number
- Names its compounding route as FDA-registered 503A and 503B pharmacies
- No membership or subscription fee on top, by its own FAQ
- "No credit card required. You only pay if approved."
The caveats
- It carries an FDA warning letter from February 2026 about false or misleading claims for the compounded semaglutide and tirzepatide sold on this website
- "$133/month" is a prepaid three-month package at $399 — no month-to-month rate is published
- Semaglutide is advertised throughout with no published price of its own
- It does not say which states it serves
- No cancellation policy is published
Fifty 410 for mothers: our verdict
The regulatory record comes first here because it is about this website: in February 2026 the FDA wrote to Aspen Aesthetics, trading as Fifty 410, over false or misleading claims concerning the compounded semaglutide and tirzepatide sold on fifty410.com. On price, the tiles need reading twice — "$133/month" appears beside "$399 total (3 months)", so it is a prepaid quarter divided by three rather than a rate you can start and stop. The higher tier is $549 for three months. Semaglutide is named in the product headings throughout but carries no price of its own, and the site does not say which states it covers.
We weigh Fifty 410 the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Fifty 410 actually costs
- Compounded tirzepatide — Starter, 3-month prepaid: $133/mo
- Compounded tirzepatide — High dose, 3-month prepaid: $183/mo
That figure is a 3-month rate, not a month-to-month one, so it is not directly comparable to the roughly $179/month median across our roster — you are committing to the full term to reach it.
The medications Fifty 410 prescribes
Fifty 410 prescribes tirzepatide, the dual GIP/GLP-1 agonist often preferred where insulin resistance drives weight. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Fifty 410 fits — and where it doesn't — for mothers
Worth it if…
- you want a straightforward tirzepatide program and will confirm the details before you commit.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you want frictionless cancellation — the fine print here is where the complaints cluster.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in Fifty 410's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Fifty 410 is a provider we list only with full disclosure — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Very few people, and none before reading the FDA letter — then only someone content to prepay three months at once.
Alternatives to Fifty 410
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Fifty 410
Head-to-head & alternatives
Fifty 410, answered
- How much does Fifty 410 cost?
- Fifty 410 doesn't post a standard monthly cash price — pricing depends on insurance or appears after an intake. Get a written quote and confirm the ongoing rate before committing.
- Is Fifty 410 safe to use while breastfeeding?
- No GLP-1 has been shown to be safe in pregnancy or while nursing, whether compounded or brand-name, and the labeling advises against it. That applies to Fifty 410 as much as to anyone else. Time it for after weaning, and make the decision with your own clinician.
- Does Fifty 410 offer both semaglutide and tirzepatide?
- Yes — Fifty 410 offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Fifty 410 rank for mothers?
- Fifty 410 takes 32/100 in our Editors' Rating, placing it #298. Six factors chosen for mothers feed that number, and CoreAge Rx is the one at the top of the list — see how they compare.
Pricing, states and verification reflect Fifty 410's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.